Positive news: HPV vaccine provides long-term protection
A new Swedish study shows that the HPV vaccine reduces the risk of cervical cancer for at least 18 years, with those vaccinated before age 17 experiencing nearly an 80% lower risk than unvaccinated women.
A new study explains how rare thrombosis occurs after Covid-19 vaccines
A new study reveals the mechanisms behind rare but serious complications following adenovirus-based Covid-19 vaccinations, known as vaccine-induced immune thrombotic thrombocytopenia (VITT).
New nasal spray could protect against viruses and bacteria
A recent study suggests that a new nasal spray could serve as a protective tool against viruses and bacteria, potentially becoming essential in the fight against future pandemics.
Vaccine-skeptic researchers: Fear of illness is less than fear of vaccine side effects
A study led by researcher Mia-Marie Hammarlin reveals that vaccine skeptics often prioritize concerns over side effects over the fear of illness itself.
African state cancels US-funded vaccine study
Guinea-Bissau has canceled a US-funded hepatitis B vaccine study after the World Health Organization expressed ethical concerns about its design.
New study: booster vaccinations reduced severe consequences of COVID-19
A recent study published in the journal 'Vaccine' shows that booster vaccinations significantly decreased the incidence of severe COVID-19 outcomes, with similar efficacy found for Moderna and Pfizer/BioNTech boosters, though protection waned over time.
Africa: All of Africa Today - February 16, 2026
The World Health Organization criticized a hepatitis B vaccine trial in Guinea-Bissau as unethical, resulting in the halt of the study.
A routine vaccine against shingles can offer a powerful defense against dementia
A study suggests that the shingles vaccine may play a role in protecting against dementia, a condition projected to affect millions more people in the coming years.
HPV vaccine shows lasting protection after 12 years, study indicates
A population study in Scotland shows that the HPV vaccination has long-lasting effects, with a sustained reduction in high-grade cervical lesions among over 270,000 women monitored for up to 12 years.
Controversial Vaccine Study on Newborns in Guinea-Bissau Canceled
A controversial US-funded study on hepatitis B vaccines for newborns in Guinea-Bissau has been canceled following ethical concerns and criticisms regarding withholding an effective vaccine from a control group.
This might be a breakthrough in the fight against fentanyl. Vaccine trials are starting
A phase 1/2 study for a novel vaccine aimed at protecting against the effects of fentanyl will begin in early 2026 in the Netherlands with around 40 healthy adult volunteers.